Valuation: PeptiDream Inc.

Market Cap 131B 809M 708M 653M 604M 1.15B 77.24B 1.17B 7.82B 3.06B 37.93B 3.04B 2.97B P/E 2026 *
9.24x
P/E 2027 * 9.17x
Enterprise Value 102B 626M 548M 505M 468M 887M 59.79B 902M 6.05B 2.37B 29.36B 2.35B 2.3B EV / Sales 2026 *
2.27x
EV / Sales 2027 * 1.98x
Free-Float
72.4%
Yield 2026 *
-
Yield 2027 * 0.59%
1 week+1.44%
Current month-3.95%
1 month+0.59%
3 months-20.74%
6 months-41.47%
Current year-38.27%
1 week 1,003.5
Extreme 1003.5
1,066.5
1 month 916
Extreme 916
1,092
Current year 916
Extreme 916
1,788
1 year 916
Extreme 916
1,818.5
3 years 916
Extreme 916
3,060
5 years 916
Extreme 916
4,950
10 years 916
Extreme 916
6,540
Manager TitleAgeSince
Chief Executive Officer 51 2021-12-31
Chief Operating Officer - 2026-07-01
Chief Tech/Sci/R&D Officer - 2024-03-31
Director TitleAgeSince
Director/Board Member 51 2008-07-31
Director/Board Member 51 2017-08-31
Director/Board Member 55 2021-02-28
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+1.44%-33.24%-48.49% 808M
-0.38%-3.44%+71.35%+126.62% 56.71B
+4.91%-3.30%+71.97%+92.14% 51.3B
+1.24%+5.87%+22.47%+479.17% 25.26B
-0.48%-4.61%-16.76%-13.39% 23.65B
+3.93%+7.11%+44.20%-1.96% 18.69B
+2.01%+2.99%+40.72%-24.46% 17.71B
-6.84%+4.81%+201.88%+348.11% 17.7B
-0.92%+8.90%+38.48% - 14.26B
+1.09%+1.73%+28.92%+197.93% 14.1B
Average +0.46%+3.25%+47.00%+128.41% 24.02B
Weighted average by Cap. +1.00%+2.16%+58.12%+142.25%

Financials

2026 *2027 *
Net sales 44.71B 275M 241M 222M 206M 390M 26.29B 397M 2.66B 1.04B 12.91B 1.03B 1.01B 46.18B 284M 249M 229M 212M 403M 27.15B 410M 2.75B 1.08B 13.33B 1.07B 1.04B
Net income 14.32B 88.22M 77.17M 71.17M 65.85M 125M 8.42B 127M 852M 334M 4.14B 331M 324M 14.42B 88.8M 77.68M 71.64M 66.28M 126M 8.48B 128M 858M 336M 4.16B 333M 326M
Net Debt -29.67B -183M -160M -147M -136M -259M -17.45B -263M -1.77B -692M -8.57B -686M -671M -40.03B -247M -216M -199M -184M -349M -23.53B -355M -2.38B -934M -11.56B -926M -906M
Logo PeptiDream Inc.
PeptiDream Inc. is a Japan-based bio-venture company started by the University of Tokyo and principally engaged in the discovery and development of non-standard peptide therapeutics. The Company operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The Company is involved in the business centered on drug development based on special peptides. The Company's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
Employees
745
Date Price Change Volume
26-07-09 JP¥1,022.50 0.00% 570,100
26-07-08 JP¥1,022.50 -2.01% 836,100
26-07-07 JP¥1,043.50 +0.34% 763,100
26-07-06 JP¥1,040.00 +1.17% 845,700
26-07-03 JP¥1,028.00 -2.05% 873,400
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1,022.50JPY
Average target price
2,825.00JPY
Spread / Average Target
+176.28%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4587 Stock